Canine Leptospirosis Market Outlook:
Canine Leptospirosis Market size was over USD 1.01 billion in 2025 and is anticipated to cross USD 1.88 billion by 2035, witnessing more than 6.4% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of canine leptospirosis is assessed at USD 1.07 billion.
The growth of this market can be primarily driven by the increased prevalence of infectious leptospirosis globally. Furthermore, the increasing transfer of infection from animals to humans is boosting the growth of the market. A study published in the journal Pathogen in March 2022 found that leptospirosis infection in humans is one of the leading and neglected causes of morbidity and mortality, with more than 1 million cases per year and approximately 60,000 people being found dead.
The global pet ownership is on the rise, with more and more people welcoming dogs into their families. This expanding pet population spreads to a larger pool of potential candidates for leptospirosis vaccination and treatment as a result driving the market growth of the canine leptospirosis market in the projected time period.
